When a stock hits a fresh low, it can either signal a dirt cheap dream stock or a dreadful stock to avoid. Separating the wheat from the chaff is difficult, but finding well-run companies at bargain-basement prices is a great way to accumulate a fortune over the long run.
With that in mind, we'll use the aggregate intelligence of the 125,000-plus investors participating in Motley Fool CAPS to see what the community is saying about stocks hitting 52-week lows today. The community's approval (signified by four- and five-star ratings) could indicate that further research is in order.
Here are two such stocks:
| Company |
Today’s Intraday Price |
Industry |
CAPS Rating (out of 5) |
Fools Saying Outperform |
|---|---|---|---|---|
|
BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN) |
$12.31 |
Biotechnology |
|
868 of 911 |
|
National Instruments Corp (NASDAQ:NATI) |
$18.48 |
Electronic Equipment, Instruments and Components |
|
315 of 331 |
Source: Motley Fool CAPS, as of Feb. 19, 2009.
Top-rated biotechnology companies:
- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA): Stock price is 41% higher than last year.
- Cephalon, Inc. (NASDAQ:CEPH): Stock price is 22% higher than last year.
Top-rated chemicals companies:
- Sociedad Quimica y Minera (ADR) (NYSE:SQM): Stock price is 75% higher than last year.
- Balchem Corp (NASDAQ:BCPC): Stock price is 1% higher than last year.
Join us on CAPS to learn more about these and countless other interesting stock ideas.
